Glycologix, Inc. — Form D
Glycologix, Inc. of BEVERLY, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-23. The offering totals $1.8M, of which $1.1M was reported sold. Industry: Other Technology.
Offering
- Filed: 2023-05-23
- Form: D
- Accession: 0001903671-23-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $1.8M
- Amount sold: $1.1M
- Remaining: $649K
- Minimum investment: $5K
- Investors: 25
- Date of first sale: 2023-05-15
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-482422
Issuer
- Name: Glycologix, Inc.
- CIK: 0001903671
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 100 CUMMINGS CENTER, SUITE 451C, BEVERLY, MA, 01915
- Phone: 6174802536
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Michael Chester | Director | Santa Monica, CA |
| George Adaniya | Director | Beverly, MA |
| Daniel Deardorf | Director | Beverly, MA |
| Daniel Deardorf | Executive Officer | Beverly, MA |
| Martha Farmer | Director | Beverly, MA |
| Michael Marsh | Director | TRAVERSE CITY, MI |
| Douglas Smith | Executive Officer | San Francisco, CA |
Other filings by this issuer (3)
More